• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

Jim Cramer: My Best Stock Picks for Cannabis and China

And why I won't recommend any other stocks in these markets, right now.
By JIM CRAMER Feb 28, 2019 | 07:08 AM EST
Stocks quotes in this article: CGC, CRON, GWPH, BIDU, NIO, BABA, STZ, MO, AMZN

People want me to recommend every cannabis stock. No, I won't. I will only recommend Canopy Growth (CGC) , Cronos Group (CRON) and GW Pharmaceuticals (GWPH) .

People want me to recommend every Chinese stock. No, I won't. I will only recommend Alibaba (BABA)  -- although on pullbacks I like Baidu (BIDU) , and now, perhaps Nio (NIO) , although I have not yet completed the work-up on the latter, so I can't yet tell you to buy it, after it's up 40% for the year.

Why not?

Why not just say, "Yeah I like that stock. In fact I like that sector."

Because of the risk and reward. Or I should say the reputational risk and the losses you might experience if I bless more than I am doing now.

Why is that? I want to go over with you my reasons for being so adamant about recommending those and no others -- at least right now.

Let's take cannabis first.

I have spent a lot of time with Canopy. I have had many lunches and meetings and interviews with Bruce Linton, the chairman, co-CEO and co-founder of Canopy, which is attempting to be the dominant seller of both recreational cannabis and medical cannabis. It has made great strides doing so -- and, by last count, already has 30% of the burgeoning Canadian market.

In truth, though, the real reason I like it is because Constellation Brands (STZ) has done the due diligence for me. The fastest-growing major beer company could have invested in any company, but it picked Canopy to give $4 billion dollars to in order to effectively control the company. If you want to see how that was done, I ran a teach-in with Bill Newlands, the soon-to-be CEO of Constellation. It made me doubly sure that Canopy is worth recommending. How can you out-due-diligence Constellation?

I admit I was more skeptical of Cronos. But CEO Mike Gorenstein has similar ambition to Canopy, and it has the backing of Altria Group (MO) , which gave the company $1.8 billion to help them develop the infrastructure to be a global player in cannabis. Again, Altria's got gravitas -- and Mike Gorenstein, the chairman, president and CEO of Cronos, seems like a real straight shooter.

GW Pharma? What can I say. It's the chicken way to play cannabis, because it is a medical company. What makes it any different from Cronos and Canopy? FDA approval. It's got it, they don't. You can dose it because it is uniform; doctors love that. It's only been approved for a horrendous form of epilepsy for children. Millions of people suffer from epilepsy -- read Kurt Eichenwald's book, A Mind Unraveled, if you want to know how bad it is. This $5 billion company deserves a much-bigger market cap because of those possibilities and its status as the anointed legal pharma in the space.

The other companies? They don't have the pedigree, infrastructure partners, or in GW's case, blessing, to make me like them. And you don't need to like them all to make money, especially when they get really extended and you have to trade them not invest in them.

How about China? I like Baidu because it's been hammered and the internet search engine has a monopoly because Google doesn't have a presence in China. I am interested in Nio because of the need for electric cars in China, as pollution is so bad there and a million people die every year from respiratory illnesses. But Alibaba is my favorite, because it is the Amazon (AMZN) of China -- and that's a gigantic market. And it has U.S.-like financials. It, too, is a terrific buy on weakness.

Again, you don't need to recommend every Chinese stock to participate in a market that could blow up if President Trump does to China what he just did to North Korea.

What if I do more of these? These are the two riskiest segments of the entire market. I can really hurt people in these. At least when these picks go down, I can tell you to buy more.

What can I say? These are the home of the best, and I am going to leave the raggedy rest to others.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Action Alerts Plus, which Cramer co-manages as a charitable organization, is long AMZN.

TAGS: Fundamental Analysis | Investing | Markets | Stocks | Biotechnology | Marijuana | Retail | Technology | Global Equity | Cannabis |

More from Stocks

You Don't Have to Trade All at Once

James "Rev Shark" DePorre
Sep 23, 2023 10:00 AM EDT

Trading in multiple time frames not only reduces risks, but also provides strategic flexibility. Let me show you what I mean and how to do it.

FS Insight Weekly Roadmap: Market Response to Hawkish Fed Is an Overreaction

Tom Lee and the FSI Team
Sep 23, 2023 9:10 AM EDT

Here's why we believe 'higher for longer DUE to higher GDP' has a more dovish tone, and remain constructive for the rest of the year.

This Dividend Aristocrat Has All the Raw Materials to Make It a Top Pick

Bob Ciura
Sep 23, 2023 7:30 AM EDT

This name has been down, but now I think it's charged up to cruise into the year's end.

The Bears Just Moved Into Wall Street

James "Rev Shark" DePorre
Sep 22, 2023 4:26 PM EDT

Technically, the bears are in control of this market now.

Don't Be a Sap and Step Into a Value Trap

Bret Jensen
Sep 22, 2023 12:30 PM EDT

There are plenty of stocks that look like value plays but aren't as the market continues to drag more share prices down.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:20 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Trading in Multiple Time Frames
  • 10:24 AM EDT BRUCE KAMICH

    This Could Get Messy

    A number of key stocks are getting close to import...
  • 01:41 PM EDT CHRIS VERSACE

    Latest AAP Podcast With Helene Meisler!

    Listen in as the Action Alerts PLUS podcast talks ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login